lomerizine has been researched along with Papilledema in 1 studies
lomerizine: used to treat migraines
Papilledema: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Savigni, DL | 1 |
| O'Hare Doig, RL | 1 |
| Szymanski, CR | 1 |
| Bartlett, CA | 1 |
| Lozić, I | 1 |
| Smith, NM | 1 |
| Fitzgerald, M | 1 |
1 other study available for lomerizine and Papilledema
| Article | Year |
|---|---|
Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma.
Topics: Adenosine Triphosphate; Animals; Basic Helix-Loop-Helix Transcription Factors; Calcium Channel Block | 2013 |